Bookstore and restaurant closures are among the 26 moments and trends that hit Singapore in 2024. Read more at ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

INR:1659. sivasspor vs kasımpaşa lineups Novo Nordisk's Ozempic has been submitted to EMA Following Roche and Takeda, Sosei wins another $480 m ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock ...